Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 9Unknown 2Withdrawn 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma 10Lymphoma, Large B-Cell, Diffuse 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Follicular 5Burkitt Lymphoma 4Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Sarcoma 2Retinoblastoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large-Cell, Anaplastic 2Immunoblastic Lymphadenopathy 2Dendritic Cell Sarcoma, Interdigitating 2Central Nervous System Neoplasms 2Waldenstrom Macroglobulinemia 1Vomiting 1Sezary Syndrome 1Recurrence 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Nausea 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Primary Effusion 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Topotecan 2Ifosfamide 2Etoposide 2trioctyl phosphine oxide 1indolepropanol phosphate 1imetelstat 1Vincristine 1Transplantation 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Pentetic Acid 1Minocycline 1Melphalan 1Heparin 1Glutamine 1GRN163L peptide 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1Busulfan 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neuroectodermal Tumors, Primitive, Peripheral × Vincristine × Clear all
NCT00334867 2013-06-28

Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma

Children's Oncology Group

Phase 3 Withdrawn
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡